会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 14. 发明授权
    • SYSTEM FOR PERFORMING ENDOVASCULAR PROCEDURES
    • 系统进行endovasculaar程序
    • EP0819013B1
    • 2004-06-23
    • EP96908744.4
    • 1996-03-11
    • HEARTPORT, INC.
    • STEVENS, John, H.PETERS, William, S.STERMAN, Wesley, D.GIFFORD, Hansen, S., III
    • A61M29/00A61M25/00A61M25/10
    • A61M25/1011A61M25/0041A61M25/0152A61M2025/0161
    • This invention is a system for inducing cardio-plegia arrest and performing an endovascular procedure within the heart or blood vessels of a patient. An endo-aortic partitioning catheter (10) has an inflatable balloon (11) which occludes the ascending aorta (12) when inflated. Cardio-plegia fluid may be infused through a lumen of the endo-aortic partitioning catheter (39) to stop the heart while the patient's circulatory system is supported on cardiopulmonary bypass. One or more endovascular devices (500) are introduced through an internal lumen (40) of the endo-aortic partitioning catheter (30) to perform a diagnostic or therapeutic endovascular procedure within the heart or blood vessels of the patient. Surgical procedures such as coronary artery bypass surgery or heart valve replacement may be performed in conjunction with the endovascular procedure while the heart is stopped. Embodiments of the system are described for performing, e.g., fiberoptic angioscopy of structures within the heart and its blood vessels, and valvuloplasty for correction of valvular stenosis.
    • 本发明是一种用于诱导心脏 - 心脏骤停并在患者的心脏或血管内执行血管内手术的系统。 内 - 主动脉分隔导管(10)具有可膨胀气囊(11),其在充气时阻塞升主动脉(12)。 可以通过主动脉分隔导管(39)的内腔注入心血液,以在体外循环支持患者的循环系统时阻止心脏。 通过内主动脉分隔导管(30)的内​​腔(40)引入一个或多个血管内装置(500)以在患者的心脏或血管内执行诊断或治疗性血管内手术。 当心脏停止时,可以结合血管内手术进行外科手术,如冠状动脉搭桥手术或心脏瓣膜置换术。 该系统的实施例被描述用于执行例如心脏及其血管内的结构的纤维血管镜检查以及用于矫正瓣膜狭窄的瓣膜成形术。